Apellis Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Apellis Pharmaceuticals, Inc. (APLS) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.410.350.550.640.570.350.18
Short-Term Investments0.000.000.010.060.310.000.00
Cash & Short-Term Investments0.420.350.550.700.880.350.18
Accounts Receivable0.270.210.010.080.030.000.00
Inventory0.080.150.090.020.000.000.00
Other Current Assets0.020.000.010.010.000.000.00
Total Current Assets0.790.770.720.820.920.370.20
Non-Current Assets
Property, Plant & Equipment (Net)0.020.020.020.030.020.010.00
Other Non-Current Assets0.080.000.020.000.000.000.00
Total Non-Current Assets0.100.020.040.060.040.010.00
Total Assets0.890.790.760.880.960.390.20
Current Liabilities
Accounts Payable0.040.040.040.020.010.060.02
Short-Term Debt0.010.000.000.000.000.000.00
Accrued Liabilities0.140.130.100.100.110.000.00
Other Current Liabilities0.140.080.030.010.000.000.00
Total Current Liabilities0.190.250.170.130.130.070.02
Non-Current Liabilities
Long-Term Debt0.460.090.090.190.360.150.03
Other Non-Current Liabilities0.010.240.320.350.250.000.00
Total Non-Current Liabilities0.470.350.420.550.630.290.03
Total Liabilities0.660.590.590.680.760.360.04
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-3.04-2.84-2.31-1.66-0.93-0.58-0.28
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital3.273.042.481.861.130.620.44
Shares Outstanding0.120.120.110.100.000.000.00
Total Stockholders' Equity0.230.190.170.200.200.030.16
Total Liabilities & Equity0.890.790.760.880.960.390.20